NextGem venture explores self-renewing human hematopoietic stem cells

NextGem has basic technologies to identify and isolate hematopoietic stem cells which are active over a long time, a very small portion of hematopoietic stem cells with the proportion of around 1 cell in 100,000 cells of mouse bone marrow cells. The company applies AI...